Phathom Shares Plunge 23% After BDR Suit Over VOQUEZNA Exclusivity
Phathom Pharmaceuticals said BDR Pharmaceuticals sued the FDA over exclusivity for its key drug VOQUEZNA. Phathom shares fell roughly 23% on Friday.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.